Anbio Biotechnology Class A (NNNN) Ownership
NNNN ownership summary
as of October 18, 2026- Institutions
- 5.0% of shares outstanding
- Insiders
- 4.78% of shares outstanding
- Shares outstanding
- 43.9M
- Float
- 39.7M shares available to trade
- Short interest
- 0.12% 54K shares short
- Days to cover
- 0.23 short interest up 4.5% vs prior month
- Institutions 5.01%
- Insiders 4.78%
- Other investors 90.21%
NNNN top institutional holders
14 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 0.06% | 27K | $83,684 | +973 (+3.8%) | June 30, 2026 |
| 2 | Bank of America Corp | 0.03% | 13K | $42,001 | +13,419 (0.0%) | June 30, 2026 |
| 3 | BNP Paribas Arbitrage, SA | 0.03% | 12K | $36,934 | +1,400 (+13.5%) | June 30, 2026 |
| 4 | Marshall Wace Asset Management Ltd | 0.03% | 12K | $36,001 | +11,502 (0.0%) | June 30, 2026 |
| 5 | Morgan Stanley - Brokerage Accounts | 0.02% | 7,231 | $22,633 | −107 (−1.5%) | June 30, 2026 |
| 6 | UBS Group AG | <0.01% | 828 | $2,592 | −5,511 (−86.9%) | June 30, 2026 |
| 7 | EverSource Wealth Advisors, LLC | <0.01% | 187 | $585 | −79 (−29.7%) | June 30, 2026 |
| 8 | Advisor Group Holdings, Inc. | <0.01% | 77 | $241 | +77 (0.0%) | June 30, 2026 |
| 9 | JPMorgan Chase & Co | <0.01% | 53 | $166 | +53 (0.0%) | June 30, 2026 |
| 10 | Bare Financial Services Inc | 0.00% | 15 | $47 | — | June 30, 2026 |
| 11 | Larson Financial Group, LLC | 0.00% | 5 | $16 | +5 (0.0%) | June 30, 2026 |
| 12 | Silver Grove Financial Group, Inc. | 0.00% | 4 | $13 | +4 (0.0%) | June 30, 2026 |
| 13 | Wells Fargo & Co | 0.00% | — | — | −100 (−100.0%) | June 30, 2026 |
| 14 | Ronald Blue Trust, Inc. | 0.00% | — | — | −5 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 14, 8 holders added 27K shares and 5 cut 5,802.
NNNN top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | State Street® SPDR® S&P® Intl Sm Cp ETF | 0.06% | 26K | $80,153 | — | September 30, 2026 |
| 2 | Fidelity Nasdaq Composite Index | 0.05% | 22K | $69,514 | −4,527 (−16.9%) | August 31, 2026 |
| 3 | Northern Small Cap Core I | 0.02% | 7,140 | $22,348 | +7,140 (0.0%) | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
NNNN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns NNNN
Institutional investors own 5.0% of Anbio Biotechnology's shares and insiders 4.78%. The largest holder is Geode Capital Management, LLC with 0.06% of the shares (27K), as of June 30, 2026. Among the top 14 institutions, 8 added shares and 5 reduced their stake in the latest filings. Short interest is 0.12% of the float, or 0.23 days of average trading volume. The share count rose 3.8% since 2023.
Related: NNNN key metrics. See the NNNN stock overview for the latest quote and news.
NNNN ownership FAQ
Who owns the most Anbio Biotechnology stock?
The largest shareholders of Anbio Biotechnology are Geode Capital Management, LLC (0.06%), Bank of America Corp (0.03%), BNP Paribas Arbitrage, SA (0.03%), Marshall Wace Asset Management Ltd (0.03%), Morgan Stanley - Brokerage Accounts (0.02%).
What percentage of Anbio Biotechnology is owned by institutions?
Institutions hold 5.0% of Anbio Biotechnology's shares outstanding; insiders hold 4.78%.
Which funds own Anbio Biotechnology?
The largest fund holders of Anbio Biotechnology are State Street® SPDR® S&P® Intl Sm Cp ETF (0.06%), Fidelity Nasdaq Composite Index (0.05%), Northern Small Cap Core I (0.02%).
What is Anbio Biotechnology's short interest?
54K shares of Anbio Biotechnology were sold short, 0.12% of the float; at the average daily volume it would take 0.23 days to cover.
How many shares of Anbio Biotechnology are outstanding?
Anbio Biotechnology has 43.9M shares outstanding, of which 39.7M are in the public float.